<DOC>
	<DOCNO>NCT02517827</DOCNO>
	<brief_summary>The endovascular therapy prevail nearly region peripheral artery disease open surgery technique . However , treatment common femoral artery vascular surgery still gold standard therapy . One-year patency rate 90 % 95 % . Today , select case endovascular procedure common femoral artery disease recommend . The primary objective study compare performance directional atherectomy drug-coated balloon angioplasty vascular surgery common femoral artery lesion prospective , multi-center , randomized clinical trial .</brief_summary>
	<brief_title>Percutaneous Intervention Versus Surgery Treatment Common Femoral Artery Lesions</brief_title>
	<detailed_description>Multicenter , prospective , randomize study conduct center Europe . A total 260 subject enter study randomize 1:1 basis either directional atherectomy drug coat balloon angioplasty ( optional stentimplantation ) , surgical endarterectomy treatment symptomatic ( Rutherford-Becker class 2 4 ) common femoral artery disease . All subject undergo repeat duplex-ultrasound measurement 6 , 12 , 24 month assess primary endpoint Binary Restenosis . Follow-up visit schedule 6 , 12 , 24 month .</detailed_description>
	<mesh_term>Peripheral Arterial Disease</mesh_term>
	<mesh_term>Paclitaxel</mesh_term>
	<mesh_term>Albumin-Bound Paclitaxel</mesh_term>
	<criteria>1 . Subject must 21 85 year old ; 2 . Female childbearing potential must negative pregnancy test within 10 day prior index procedure utilize reliable birth control completion 12month angiographic evaluation ; 3 . Clinical diagnosis symptomatic peripheral artery disease define Rutherford 2 , 3 , 4 ; 4 . Common femoral artery stenosis &gt; 70 % diameter stenosis ( visual estimate ) ; Additional nontarget lesion ( ) remain nontarget vessel ( ) , except ipsilateral iliac artery , treat physician´s discretion ; 5 . At least one vessel outflow ( infrapopliteal artery ) foot ( without stenosis &gt; 50 % ) . 6 . Endovascular Procedure : Guidewire must across target lesion locate intraluminally within distal vessel study randomization ; 7 . Interventions TASC A B lesion restore adequate blood flow , index procedure allow . This intervention must prior treatment study lesion successful ; 8 . Willing comply specify followup evaluation ; 9 . Written inform consent prior study procedure . 1 . Ipsilateral significant ( &gt; 50 % ) stenosis iliac artery . 2 . Significant ( &gt; 50 % ) stenosis infrapopliteal artery , patent artery foot . 3 . Angiographic evidence thrombus within target vessel ; 4 . Thrombolysis within 72 hour prior index procedure ; 5 . InStent restenosis restenosis native common femoral artery . 6 . Aneurysm abdominal aorta iliac artery ; 7 . Concomitant hepatic insufficiency , thrombophlebitis , deep venous thrombus , coagulation disorder receive immunosuppressant therapy ; 8 . Recent MI stroke &lt; 30 day prior index procedure ; 9 . Life expectancy le 24 month ; 10 . Known suspect active infection time index procedure ; 11 . Known suspected allergy contraindication aspirin , clopidogrel bisulfate ( Plavix ) ticlopidine ( Ticlid ) , heparin , contrast agent ; 12 . Any significant medical condition , investigator´s opinion , may interfere subject´s optimal participation study ; 13 . The subject currently participate another investigational drug device study complete primary endpoint clinically interfere endpoint study .</criteria>
	<gender>All</gender>
	<minimum_age>21 Years</minimum_age>
	<maximum_age>85 Years</maximum_age>
	<verification_date>November 2016</verification_date>
	<keyword>common femoral artery</keyword>
	<keyword>drug-coated balloon</keyword>
	<keyword>surgical endarterectomy</keyword>
</DOC>